pharmacyclics | Pharmacyclics

Keyword	CPC	PCC	Volume	Score	Length of keyword
pharmacyclics	1.67	0.3	7382	39	13

Keyword	CPC	PCC	Volume	Score
pharmacyclics	0.9	0.8	7392	47

Search Results related to pharmacyclics on Search Engine

Pharmacyclics
pharmacyclics.com

https://www.pharmacyclics.com/

WebPharmacyclics is an AbbVie company based in the Bay Area, California. Our charge is to help people impacted by cancer and immune-mediated diseases by focusing on the development of safe and effective treatment options. We will know that our mission has been achieved when patients and their families have rediscovered the Magic of Normal ...

DA: 1 PA: 81 MOZ Rank: 8

Pharmacyclics - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Pharmacyclics

WebPharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. It is primarily focused on the development of cancer therapies. In 2017, Xynomic Pharmaceuticals acquired all global rights to Abexinostat, Pharmacyclics' primary commercial product. Acquisition by AbbVie

DA: 44 PA: 27 MOZ Rank: 74

AbbVie to Acquire Pharmacyclics, including its blockbuster …
abbvie.com

https://investors.abbvie.com/news-releases/news-release-details/abbvie-acquire-pharmacyclics-including-its-blockbuster-product

WebMar 4, 2015 · Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company's mission is to build a viable biopharmaceutical company that designs, develops and commercializes novel …

DA: 12 PA: 29 MOZ Rank: 61

Areas of Study - Pharmacyclics
pharmacyclics.com

https://www.pharmacyclics.com/home/areas-of-study.html

WebPhase 3. Ibrutinib w/ Venetoclax vs. Chlorambucil w/ Obinutuzumab. Chronic Lymphocytic Leukemia/. Small Lymphocytic Lymphoma. (CLL/SLL) First Line Treatment. Young/Fit Patients. Phase 2. Venetoclax +/- Ibrutinib.

DA: 40 PA: 67 MOZ Rank: 67

Pharmacyclics’ ‘miracle cure’: A cancer drug saves a biotech …
seattletimes.com

https://www.seattletimes.com/business/technology/pharmacyclics-miracle-cure-a-cancer-drug-saves-a-biotech-company/

WebJan 9, 2016 · SUNNYVALE, Calif. — Biotech company Pharmacyclics was teetering toward bankruptcy. Its one big product had flopped. Its top chemist, co-founders and entire board resigned, frustrated and ...

DA: 70 PA: 80 MOZ Rank: 12

Pharmacyclics, an AbbVie Company | LinkedIn
linkedin.com

https://www.linkedin.com/company/pharmacyclics

WebPharmacyclics, an AbbVie Company | 28,135 followers on LinkedIn. Striving to bring back the magical of normal. | Pharmacyclics is committed to the development and commercialization of novel ...

DA: 25 PA: 73 MOZ Rank: 75

News Center | AbbVie News Center
abbvie.com

https://news.abbvie.com/news/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica-creating-an-industry-leading-hematological-oncology-franchise.htm

WebAbbVie, a global biopharmaceutical company, announced its plan to buy Pharmacyclics, the maker of Imbruvica, a breakthrough drug for blood cancers. Learn more about this deal and how it will enhance AbbVie's leadership in hematological oncology.

DA: 82 PA: 37 MOZ Rank: 83

Healthcare Professionals - pharmacyclics.com
pharmacyclics.com

https://www.pharmacyclics.com/home/healthcare-professionals.html

WebWe are here to partner with you and make a difference. As your partner in care, we are here to collaborate with you to help make positive differences in the health and well-being of patients. Together, we can work to provide transformative therapies for patients with unmet medical need. Below are resources that may be helpful for you or your ...

DA: 33 PA: 66 MOZ Rank: 3

News Center | AbbVie News Center
abbvie.com

https://news.abbvie.com/news/abbvie-completes-acquisition-pharmacyclics.htm

WebNews Center | AbbVie News Center

DA: 83 PA: 18 MOZ Rank: 78

AbbVie to Acquire Pharmacyclics, including its blockbuster …
fiercepharma.com

https://www.fiercepharma.com/pharma/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica%C2%AE-creating-an

WebMar 4, 2015 · Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

DA: 77 PA: 89 MOZ Rank: 84